Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 6, 2012, Pages 422-429

  Alemzadeh, Ramin ^a   Kichler, Jessica ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM ION; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CALCIUM BLOOD LEVEL; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; AFRICAN AMERICANS; AGE OF ONSET; BIOLOGICAL MARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84869838117     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0056     Document Type: Article

References (50)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
2. Weiss R, Dziura J, Burgert TS, et al. Obesity in the metabolic syndrome in children and adolescents. N EnglJ Med 2004; 350:2362-2374. (Pubitemid 38702847)
3. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006; 97:3A-11A. (Pubitemid 43139714)
4. Kahn SE, Zinman B, Haffner SM, et al.; ADOPT Study Group. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006;55:2357-2364. (Pubitemid 44743635)
5. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230. (Pubitemid 40616645)
6. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007;92:2017-2029. (Pubitemid 46997093)
7. Guerrero-Romero F, Rodŕguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-213. (Pubitemid 35470535)
8. Reis JP, von Mü hlen D, Miller ER 3rd. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008;159:41-48. (Pubitemid 351969129)
9. Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2002;283: F367-F376.
10. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008;35:215-237. (Pubitemid 351680116)
11. Silver J, Naveh-Many T. Vitamin D and the parathyroid. In: Feldman D, Glorieux F, Wesley Pike J (eds). Vitamin D, 2nd ed. San Diego: Elsevier, 2004.
12. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825. (Pubitemid 41103882)
13. Chiu KC, Chuang LM, Lee NP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000;49:1501-1509.
14. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 2004;151:167-172. (Pubitemid 39207010)
15. McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003;61:535-542. (Pubitemid 37411898)
16. Ahlstrom T, Hagström E, Larsson A, et al. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 2009;71:673-678.
17. Hjelmesaeth J, Hofso D, Aasheim ET, et al. Parathyroid hormone, nut not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: A crosssectional study. Cardiovasc Diabetol 2009;8:1-7.
18. Richart T, Thijs L, Nawrot T, et al. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. Am J Hypertens 2011;24:102-109.
19. Røislien J, Van Calster B, Hjelmesæth J. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: A cross-sectional study. Cardiovasc Diabetol 2011;10:17.
20. Lee DM, Rutter MK, O'Neill TW, et al.; European Male Ageing Study Group. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009;161:947-954.
21. Kayaniyil S, Vieth R, Harris SB, et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 2011;96:168-175.
22. Reis JP, von Mü hlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30:1549-1555. (Pubitemid 46871169)
23. Christensen MH, Dankel SN, Nordbø Y, et al. Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue. PLoS One 2011; 6:e20481.
24. Alemzadeh R, Kichler J, Babar G, et al. Hypovitaminosis D in obese children and adolescents: Relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57:183-191.
25. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: International survey. Br Med J 2000;320:1240-1243. (Pubitemid 30240471)
26. Lommez A, Borys JM, Ducimetiere P, et al. Reliability of bioimpedance analysis compared with other adiposity measurements in children: The FLVS II Study. Diabet Metab 2005;31:534-541. (Pubitemid 43001170)
27. Lazzer S, Boirie Y, Meyer M, et al. Which alternative method to dual-energy X-ray absorptiometry for assessing body composition in overweight and obese adolescents? Arch Pediatr 2005;12:1094-1101. (Pubitemid 40835226)
28. Brasil AR, Norton RC, Rossetti MB, et al. C-reactive protein as an indicator of low intensity inflammation in children and adolescents with and without obesity. J Pediatr (Rio J) 2007; 83:477-480. (Pubitemid 47596992)
29. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004;114:555-576.
32. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategies, and statistical considerations. J Personality Soc Psychol 1986;51:1173-1182.
33. Liu S, Song Y, Ford ES, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middles-aged and older US women. Diabetes Care 2005;28:2926-2932. (Pubitemid 43942926)
34. Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: Results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87:136-141.
35. Richart T, Li Y, Staessen JA. Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening and hypertension. Am J Hypertension 2007;20:1007-1015. (Pubitemid 47313623)
36. Boucher BJ, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995;38:1239-1245.
37. Krista-Boneh E, Froom P, Harari G, et al. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997;30:1289-1294. (Pubitemid 27476193)
38. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008;52:828-832.
39. Jorder R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone and blood pressure. Hypertension 2000;35:1154-1159. (Pubitemid 30327273)
40. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: A population-based study in older men and women. J Intern Med 2007;261:558-565. (Pubitemid 46835978)
41. Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 2011;96:1320-1326.
42. Ismail A, Namala R. Impaired glucose tolerance in vitamin D deficiency can be corrected by calcium. J Nutr Biochem 2000;11:170-175. (Pubitemid 30163091)
43. Reinehr T, de Sousa G, Alexy U, et al. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225-232. (Pubitemid 47233129)
44. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294: 2336-2341. (Pubitemid 41607410)
45. Richart T, Li Y, Staessen JA. Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening and hypertension. Am J Hypertens 2007;20:1007-1015. (Pubitemid 47313623)
46. Gutiérrez OM, FarwellWR, Kermah D, et al. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011;22:1745-1753.
47. Aloia JF, Chen DG, Chen H. The 25(OH)D/PTH threshold in black women. J Clin Endocrinol Metab 2010;95:5069-5073.
48. Hagström E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Circulation 2009;119:2765-2771.
49. Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complications in the new PCOS phenotypes based on Rotterdam criteria. Fertil Steril 2007;88:1389-1395. (Pubitemid 350030974)
50. Haroun D, Crocker H, Viner RM, et al. Validation of BIA in obese children and adolescents and re-evaluation in a longitudinal study. Obesity 2009;12:2245-2250.